$ITRI

Reeves Donald L. III sold $25K of ITRI

Reeves Donald L. III (SVP, Outcomes) sold 293 shares of ITRON, INC. (ITRI) at $84.50 on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Reeves Donald L. III
Published May 28, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ITRI
Neutral
high confidence
Mentioned
$ITRI
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ITRINeutralLow
01

Why it matters

The disclosed event is an open-market sale by an officer under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no new fundamental information in the text.

03

What to watch

The article does not state whether other insiders sold/bought, nor does it provide context on total holdings changes beyond the post-transaction share count.

Relevance 2/10Novelty 2/10Timing: Filed 2026-05-28, covering a sale executed 2026-05-27.

Background

The article is an SEC Form 4 insider transaction disclosure for ITRON, Inc. (ITRI).

Company-level read

Ticker impact

$ITRINeutralHigh confidence
Context

ITRON SVP Outcomes Reeves Donald L. III sold 293 shares at $84.50 on 2026-05-27 under a 10b5-1 plan, per Form 4.

Expected impact

Likely negligible immediate price impact; any effect is more sentiment than fundamentals.

Evidence & confidence

The filing is an open-market sale by an officer, explicitly tied to a pre-arranged 10b5-1 plan, and the article provides no new operational, financial, or regulatory catalyst.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification or liquidity needs and may not reflect bearish expectations, especially under 10b5-1.

Key entities

  • ITRON, Inc.

    Company whose Form 4 insider sale is disclosed.

  • Reeves Donald L. III

    SVP, Outcomes who executed the sale under a 10b5-1 plan.

Related articles

$ITRIMedAI 8/10

Why Shares of Itron Stock Jumped 17.4% This Week

Itron shares rose about 17% this week after the company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Itron posted non-GAAP EPS of $1.59 versus $1.29 expected and cited demand for grid stability tied to AI infrastructure build-out. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMed

Why Shares of Itron Stock Jumped 17.4% This Week

Itron (NASDAQ: ITRI) shares rose about 17.4% this week, after the utility technology company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Non-GAAP EPS was $1.59 versus $1.29 expected. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMedAI 8/10

Itron Q2 Earnings Call Highlights

Itron (NASDAQ:ITRI) reported Q2 GAAP net income of $53M, or $1.19/diluted share, versus $68M a year earlier. Non-GAAP operating income rose 8% to $89M and adjusted EBITDA rose 8% to $97M. Q2 revenue by segment: Device Solutions $111M, Networked Solutions $339M, Outcomes $96M, Resiliency Solutions about $16M. Free cash flow was $81M. Backlog was $4.4B. Itron raised full-year non-GAAP EPS to $6.30-$6.50 and narrowed revenue to $2.37B-$2.41B.

$ITRIMedAI 8/10

Why Itron Stock Soared 26% Higher Today

Itron reported Q2 revenue of $563 million, down 7% year over year, and adjusted net income of $71 million, or $1.59 per share, down from $75 million. Revenue guidance was narrowed to $2.37B-$2.41B, while adjusted EPS guidance rose to $6.30-$6.50. Shares jumped about 26% after the earnings report, according to the article.